Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170716035104N1Phase 3Completed
Phase 3, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Isoflurane group with Propofol group (2 arms). Primary endpoint: Blood glucose level before and after surgery. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170716035104N1.